Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Studies on the Cost of Diabetes
 

Historical

This webpage is archived for historical purposes and is no longer being maintained or updated.

Thomas J Songer, PhD, MSc
Lorraine Ettaro, BS
and the Economics of Diabetes Project Panel

Prepared for Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Division of Diabetes Translation
Atlanta, GA

June 1998

Table of Contents

  1. Introduction
  2. Why Conduct a Cost-of-Illness Study?
  3. Actual Uses of Cost-of-Illness Estimates
  4. Methods Used in Estimating the Cost-of-Illness
  5. Cost-of-Diabetes Methods
  6. Cost-of-Diabetes Estimates – Results
  7. Cost-of-Diabetes Estimates – Comparisons
  8. Summary
  9. Limitations in Current Cost-of-Diabetes Studies
  10. A Proposed Framework for Future Research
  11. References

Tables

  1. Estimates of costs of various diseases
  2. Estimates of the economic cost of diabetes mellitus in the United States, by study
  3. Estimates of direct costs for health care services in diabetes, by study
  4. Estimates of health care utilization with data sources, by study
  5. Cost components included in estimates of direct health care costs for diabetes
  6. Estimates of indirect costs due to absenteeism, disability, and mortality from diabetes, by study
  7. Comparison of unit costs used by American Diabetes Association studies for hospital care and nursing home care

Appendices

  1. Appendix A – Price inflation and diabetes prevalence adjusters
  2. Appendix B – Direct costs, adjusted for price inflation, using Gross Domestic Product deflator, and diabetes prevalence
  3. Appendix C – Direct costs, adjusted for price inflation, using Consumer Price Index all items, and diabetes prevalence
  4. Appendix D – Direct costs, adjusted for price inflation, using Consumer Price Index medical care, and diabetes prevalence
  5. Appendix E – Direct costs, adjusted
  6. Appendix F – Economics of Diabetes Project. Summary and Key Findings of Panel Meeting. April 6-7, 1998, Atlanta, GA


Return to the Table of Contents Acknowledgements

The authors thank Judith Lave and Joseph Newhouse for comments and insight on the manuscript and access to unpublished data. This work was supported by the CDC's Division of Diabetes Translation.

Address for correspondence:    
 
 
 
Thomas J Songer, PhD, MSc
Department of Epidemiology
Graduate School of Public Health
University of Pittsburgh
Pittsburgh, PA 15261

Top of Page

 
Contact Us:
  • CDC Diabetes Public Inquiries
  • Mail
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    8am-8pm ET
    Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #